Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 97

1.

The case for semi-mandatory HPV vaccination in China.

Zhang WJ, Li F, Wang YH, Simayi D, Saimaiti A, Zou XG, Xiong CL, Gong FL, Cao YG.

Nat Biotechnol. 2013 Jul;31(7):590-1. doi: 10.1038/nbt.2631. No abstract available.

PMID:
23839139
2.

Cell-mediated immune response: a clinical review of the therapeutic potential of human papillomavirus vaccination.

Meyer SI, Fuglsang K, Blaakaer J.

Acta Obstet Gynecol Scand. 2014 Dec;93(12):1209-18. doi: 10.1111/aogs.12480. Epub 2014 Sep 20. Review.

PMID:
25146484
3.

Human papillomavirus vaccines versus cervical cancer screening.

Stanley M.

Clin Oncol (R Coll Radiol). 2008 Aug;20(6):388-94. doi: 10.1016/j.clon.2008.04.006. Epub 2008 Jun 5. Review.

PMID:
18538554
4.

Papillomavirus vaccine types 16 and 18: new drug. Cervical cancer: just another vaccine.

[No authors listed]

Prescrire Int. 2008 Jun;17(95):103-4.

PMID:
18623911
5.

Cervical cancer vaccine development.

Frazer IH.

Sex Health. 2010 Sep;7(3):230-4. doi: 10.1071/SH09132. Review.

PMID:
20719210
6.

[Vaccination perspective against human papillomavirus and consequences for the screening of uterine cervical neoplasm].

Delvenne P.

Bull Mem Acad R Med Belg. 2007;162(10-12):483-8; discussion 489-90. French.

PMID:
18557390
7.

HPV vaccination: too soon for 2 doses?

Kahn JA, Bernstein DI.

JAMA. 2013 May 1;309(17):1832-4. doi: 10.1001/jama.2013.4147. No abstract available.

PMID:
23632729
8.

Human papillomavirus vaccines: current status and future prospects.

Garland SM, Smith JS.

Drugs. 2010 Jun 18;70(9):1079-98. doi: 10.2165/10898580-000000000-00000. Review.

PMID:
20518577
9.

Fraction of cervical neoplasias due to human papillomavirus 16 and 18 in vaccine trials.

Franceschi S, Clifford GM.

Int J Cancer. 2008 Feb 1;122(3):719-20. No abstract available.

10.

HPV and cervical cancer: screening or vaccination?

Bosch FX, Castellsagué X, de Sanjosé S.

Br J Cancer. 2008 Jan 15;98(1):15-21. doi: 10.1038/sj.bjc.6604146. Epub 2008 Jan 8. Review.

11.

Integrating clinical, community, and policy perspectives on human papillomavirus vaccination.

Fernández ME, Allen JD, Mistry R, Kahn JA.

Annu Rev Public Health. 2010;31:235-52. doi: 10.1146/annurev.publhealth.012809.103609. Review.

12.

[Impact of vaccination against oncogenic human papillomavirus on the incidence and mortality of cervical cancer in Germany].

Schneider A, Schwarz TF, Hammerschmidt T, Siebert U.

Med Klin (Munich). 2007 Jul 15;102(7):515-23. German.

PMID:
17634869
13.

Indications and efficacy of the human papillomavirus vaccine.

Hakim AA, Lin PS, Wilczynski S, Nguyen K, Lynes B, Wakabayashi MT.

Curr Treat Options Oncol. 2007 Dec;8(6):393-401. doi: 10.1007/s11864-007-0050-0. Review.

PMID:
18172770
14.

[Implementation of HPV vaccination in Germany].

Schreckenberger C, Kaufmann AM, Schneider A.

Dtsch Med Wochenschr. 2007 Oct;132(42):2221-4. German. No abstract available.

PMID:
17926251
15.

Randomized trial: immunogenicity and safety of coadministered human papillomavirus-16/18 AS04-adjuvanted vaccine and combined hepatitis A and B vaccine in girls.

Pedersen C, Breindahl M, Aggarwal N, Berglund J, Oroszlán G, Silfverdal SA, Szüts P, O'Mahony M, David MP, Dobbelaere K, Dubin G, Descamps D.

J Adolesc Health. 2012 Jan;50(1):38-46. doi: 10.1016/j.jadohealth.2011.10.009.

PMID:
22188832
16.

Success of HPV vaccination is now a matter of coverage.

Schiffman M, Wacholder S.

Lancet Oncol. 2012 Jan;13(1):10-2. doi: 10.1016/S1470-2045(11)70324-2. Epub 2011 Nov 8. No abstract available. Erratum in: Lancet Oncol. 2012 Jan;13(1):e1.

PMID:
22075169
17.

Incremental cost-effectiveness evaluation of vaccinating girls against cervical cancer pre- and post-sexual debut in Belgium.

Demarteau N, Van Kriekinge G, Simon P.

Vaccine. 2013 Aug 20;31(37):3962-71. doi: 10.1016/j.vaccine.2013.06.008. Epub 2013 Jun 15.

18.

Efficacy of vaccination against HPV infection to prevent cervical cancer in France.

Ribassin-Majed L, Hill C, Lounes R.

Public Health. 2015 Jan;129(1):78-81. doi: 10.1016/j.puhe.2014.11.005. Epub 2014 Dec 24. No abstract available.

PMID:
25544659
19.

Modern screening in cervical cancer. Perspectives of HPV prophylactic vaccines.

Vlădăreanu R, Andrei C.

Rev Med Chir Soc Med Nat Iasi. 2007 Jan-Mar;111(1):144-54. Review.

PMID:
17595860
20.

Issues in human papillomavirus vaccination in adolescents.

Moscicki AB, Smith JS.

J Adolesc Health. 2008 Oct;43(4 Suppl):S1-4. doi: 10.1016/j.jadohealth.2008.07.008. No abstract available.

PMID:
18809142

Supplemental Content

Support Center